| recorded as meeting | CRUK | 12 February 2020 | — | | ministerial_meetings |
| recorded as meeting | EU Relationship Group (EURG), GSK (GlaxoSmithKline), AZ (AstraZeneca), ABPI (Association of the British Pharmaceutical Industry), BIA (BioIndustry Association), Heptares, ABHI (Association of British HealthTech Industries), CRUK (Cancer Research UK), Philips, ABPI (Association of the British Pharmaceutical Industry), GSK (GlaxoSmithKline)
OLS (Office for Life Sciences) | 4 February 2020 | — | | ministerial_meetings |
| recorded as meeting | ABPI (Association of the British Pharmaceutical Industry, BIA (BioIndustry Association), Bayer UK& Ireland, Roche, GSK (GlaxoSmithKline), DHSC (Department of Health and Social Care), OLS (Office for Life Sciences) , NHSE (NHS England), NICE (The National Institute for Health and Care Excellence), MHRA (Medicines and Healthcare products Regulatory Agency), Alzheimers Research UK, CRUK (Cancer Research UK) | 3 February 2020 | — | | ministerial_meetings |
| recorded as meeting | Pfizer | 30 January 2020 | — | | ministerial_meetings |
| recorded as meeting | Mologic | 28 January 2020 | — | | ministerial_meetings |
| recorded as meeting | Apple | 23 January 2020 | — | | ministerial_meetings |
| recorded as meeting | Oxford University | 21 January 2020 | — | | ministerial_meetings |
| recorded as meeting | Association of the British Pharmaceutical Industry | 15 January 2020 | — | | ministerial_meetings |
| recorded as meeting | GSK (GlaxoSmithKline), AZ (AstraZeneca), ABPI (Association of the British Pharmaceutical Industry), BIA (BioIndustry Association), Heptares, ABHI (Association of British HealthTech Industries), CRUK (Cancer Research UK), Philips, ABPI (Association of the British Pharmaceutical Industry), GSK (GlaxoSmithKline), OLS (Office for Life Sciences), HMRC (HM Revenue and Customs), AZ (AstraZeneca) | 8 January 2020 | — | | ministerial_meetings |
| recorded as meeting | President, Global Affairs of GlaxoSmithKline | 7 January 2020 | — | | ministerial_meetings |
| recorded as meeting | London School of Hygiene & Tropical Medicine | 4 November 2019 | — | | ministerial_meetings |
| recorded as meeting | Ultromics | 31 October 2019 | — | | ministerial_meetings |
| recorded as meeting | Bayer Plc | 31 October 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health & Social Care; Office Life Sciences; Medicines and Healthcare products Regulatory Agency; Department for International Trade; NHS England; GlaxoSmithKline; Association of the British Pharmaceutical Industry; BioIndustry Association; Heptares; Association of British HealthTech Industries; AstraZeneca; Philips | 30 October 2019 | — | | ministerial_meetings |
| recorded as meeting | Closed Loop Medicine Ltd | 30 October 2019 | — | | ministerial_meetings |
| recorded as meeting | Janssen | 30 October 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health and Social Care; Office for Life Sciences; NHSX; University of Oxford; Genomics England; NHS England; Wellcome Trust; Health Informatics; AstraZeneca; GlaxoSmithKline; Bowel Cancer UK; Cancer Research UK; Academy of Medical Royal Colleges; Genetic Alliance UK; Welsh Government; Scottish Government; Department of Health Northern Ireland; Medical Research Council | 28 October 2019 | — | | ministerial_meetings |
| recorded as meeting | The Prince of Wales�s Chair of Childhood Epilepsy; Birmingham Women�s and Children�s NHS Foundation Trust; North East Thames Regional and Great Ormond Street Hospital Foundation Trust; Guy�s and St Thomas�s NHS Foundation Trust; Newcastle upon Tyne Hospitals Foundation Trust; Genetics Alliance UK; Roald Dahl�s Marvellous Children�s Charity | 24 October 2019 | — | | ministerial_meetings |
| recorded as meeting | BioIndustry Association | 14 October 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health & Social Care; Bayer UK and Ireland; Novo Nordisk; Gr�nenthal; Almirall; Boehringer Ingelheim; Chiesi; Ipsen; Merck; Norgine; Novartis Oncology; Roche Products; Sanofi; Policy Matters | 14 October 2019 | — | | ministerial_meetings |
| recorded as meeting | Alan Turing Institute | 10 October 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health and Social Care; Office of Life Sciences; NHS England;
Department International Trade; Medicines Healthcare Regulatory Agency; GlaxoSmithKline;
AstraZeneca; Association of the British Pharmaceutical Industry; BioIndustry Association; Heptares; Cancer Research UK; Association Of British HealthTech Industries; Department for Exiting the European Union | 7 October 2019 | — | | ministerial_meetings |
| recorded as meeting | University of Birmingham | 26 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health and Social Care; Department for Business, Energy and Industrial Strategy; NHS Digital; National Institute for Health Research; Government Office for Science; Nuffield Department of Population Health; University of Oxford; NHSX; Association of Medical Research Charities; AstraZeneca; Novartis; The Medicines Company; IQVIA; Medidata Solutions; ICON plc; University College London Hospital; BERG; McKinsey Digital | 25 September 2019 | — | | ministerial_meetings |
| recorded as meeting | CMR Surgical | 23 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Cancer Research UK | 23 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Public.io; NHS Digital Academy; Blenheim Chalcot, Imperial College; Junkermann Group; Bulb; Overseas Development Institute; Oxford University | 16 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Ipsen | 12 September 2019 | — | | ministerial_meetings |
| recorded as meeting | GW Pharmaceuticals | 11 September 2019 | — | | ministerial_meetings |
| recorded as meeting | BenevolentAI | 11 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health and Social Care; Department for Exiting the European Union; Department for Business, Energy and Industrial Strategy; Office for Life Sciences; NHS England; Medicines and Healthcare products Regulatory Agency; Department for International Trade; GlaxoSmithKline; AstraZeneca; Association of the British Pharmaceutical Industry; BioIndustry Association; Association of British HealthTech Industries; Philips; Heptares; Cancer Research UK | 10 September 2019 | — | | ministerial_meetings |
| recorded as meeting | LifeArc | 10 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Bluebird Bio | 10 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Royal College of Surgeons | 10 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Department for Health and Social Care; Department for Business, Energy and Industrial Strategy; University of Oxford; UK Bio Industry; Association of British HealthTech Industry; Association of the British Pharmaceutical Industry; AstraZeneca; Pfizer; GlaxoSmithKline; Innovate UK; Johnson & Johnson: MSD; Medical Research Council; Nuffield Department of Population Health; Cambridge University Hospitals NHS Foundation Trust; NHS Digital; NHS England; SV Health Investors; Legal & General; University College Birmingham; Wellcome Trust; Science Industry Partnership; Department for International Trade; Medicines and Healthcare products Regulatory Agency | 9 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Celgene | 9 September 2019 | — | | ministerial_meetings |
| recorded as meeting | The Ehlers Danlos Society | 9 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Department for Health and Social Care; Office for Life Sciences; Accelerated Access Collaborative (AAC) Board; NHS England; National Institute for Health and Clinical Excellence; Medicines Healthcare products Regulatory Agency; Association of the British Pharmaceutical Industry; Novartis; Bayer; MSD; UK Bioindustry Association; Alzheimer�s Research UK; Cancer Research UK | 4 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Intellia Therapeutics | 4 September 2019 | — | | ministerial_meetings |
| recorded as meeting | DeepMind | 4 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Nuffield Trust | 3 September 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health and Social Care;
CogX; University of Oxford; Leeds Teaching Hospitals NHS Trust; University of Edinburgh | 2 September 2019 | — | | ministerial_meetings |
| recorded as meeting | The International Business Machines Corporation | 22 August 2019 | — | | ministerial_meetings |
| recorded as meeting | Genomics PLC; Stanford University; Queen Mary University; Great Ormond Street Hospital, King's College Londonl; NHS Engalnd; Royal College of General Practitioners; Michigan State University; University of Leicester; Genomics England; Imperial College | 5 August 2019 | — | | ministerial_meetings |
| recorded as meeting | Oxford Nanopore Technologies | 5 August 2019 | — | | ministerial_meetings |
| recorded as meeting | BioIndustry Association; Abbvie; Oxford Biomedica; Vectura; Therakind; Immunocore; Freeline; Bluebird Bio; Touchlight; GW Pharma; Cell and Gene Therapy Catapult; Medicines Discovery Catapult; Ipsen | 25 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Teenage Cancer Trust | 25 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Fujitsu | 24 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health and Social Care; Department for Exiting the European Union; Office for Life Sciences; NHS England; Medicines and Healthcare products Regulatory Agency; Department for International Trade; GlaxoSmithKline; Association of the British Pharmaceutical Industry; AstraZeneca; BioIndustry Association; Association of British HealthTech Industries; Philips; Heptares; Cancer Reasearch UK; Her Majesty's Treasury | 22 July 2019 | — | | ministerial_meetings |
| recorded as meeting | PUBLIC; Cera; Mush; Cinapsis; Jiva.ai; Abtrace; Vine Health; Healthy.io; Adzuna; Tomo | 18 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Novartis | 18 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Genetic Alliance UK | 17 July 2019 | — | | ministerial_meetings |
| recorded as meeting | British In Vitro Diagnostics Association | 17 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Illumina | 16 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Association of British Pharmaceutical Industry; GlaxoSmithKline; Astra Zeneca; Novartis; Roche; Pfizer; Eisai; Gilead; Sanofi; UCB; Merck; Biogen; BioIndustry Association; Novo Nordisk; MSD | 16 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health and Social Care; NHS Improvement; NHS Digital; Guy�s and St Thomas�s; Royal College of Physicians; University of Edinburgh; University of Birmingham; University of Leicester; National Institute for Health Research | 15 July 2019 | — | | ministerial_meetings |
| recorded as meeting | HCA Healthcare UK | 15 July 2019 | — | | ministerial_meetings |
| recorded as meeting | GlaxoSmithKline | 11 July 2019 | — | | ministerial_meetings |
| recorded as meeting | IQVIA | 9 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Johnson & Johnson | 8 July 2019 | — | | ministerial_meetings |
| recorded as meeting | University College London; Wellcome Trust | 4 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Apple | 3 July 2019 | — | | ministerial_meetings |
| recorded as meeting | British Paediatric Neurology Association | 2 July 2019 | — | | ministerial_meetings |
| recorded as meeting | British Medical Association; use MY data; Roche; Babylon Health; Medicines and Healthcare products Regulatory Agency; AstraZeneca; Association of British HealthTech Industries; Kings' Fund; Affidea UK; NHS Clinical Commissioners; NHS Digital Board; NHS England; DigitalHealth.London; Health Data Research UK; Covington and Burling LLP; Accenture UK Health; Quadrum Institute; Innovation Agency; Microsoft UK; All-Party Parliamentary Group on Medical Research; Reform; Digital Surgery Ltd; One Healthtech; Sodexo | 2 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health and Social Care; Office for Life Sciences; Department for Business, Energy and Industrial Strategy; AstraZeneca; Johnson & Johnson: Association of the British Pharmaceutical Industry; GlaxoSmithKline; North-West e-Health; UK Biobank; Novartis; Association of British HealthTech Industries; Sheffield University; Health Data Research UK; MSD; NHS Digital | 1 July 2019 | — | | ministerial_meetings |
| recorded as meeting | Supporting Wounded Veterans | 1 July 2019 | — | | ministerial_meetings |
| recorded as meeting | AstraZeneca | 27 June 2019 | — | | ministerial_meetings |
| recorded as meeting | Association of Medical Research Charities; Brain Tumour Charity; Cancer Research UK; British Heart Foundation; Medical Research Council; Diabetes UK; Arthritis Research UK; UCLH Biomedical Research Centre; Oxford Biomedical Research Centre; Russell Group; Academy Medical Sciences; Medical Schools Council � University College London; Astra Zeneca | 27 June 2019 | — | | ministerial_meetings |
| recorded as meeting | AbbVie UK | 26 June 2019 | — | | ministerial_meetings |
| recorded as meeting | Bayer UK and Ireland; Novo Nordisk; Ipsen; Norgine; Chiesi; Roche Products; Sanofi; Merck; Novartis; A.Menarini; Policy Matters | 26 June 2019 | — | | ministerial_meetings |
| recorded as meeting | Healthy.io; Guy�s and St Thomas� NHS Foundation Trust; S12 Solutions; Leicestershire Partnership NHS Trust; Diabetes UK | 25 June 2019 | — | | ministerial_meetings |
| recorded as meeting | Teva | 25 June 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health and Social Care; Office for Life Sciences; NHSX; Government Office for Science; University of Oxford; Genomics England; NHS England; Wellcome Trust; Office for Strategic Coordination of Health Research; AstraZeneca; GlaxoSmithKline; Bowel Cancer UK; Cancer Research UK; Academy of Medical Royal Colleges; Independent industry representative; Genetic Alliance UK; Welsh Government; Scottish Government; Department of Heath Northern Ireland; Medical Research Council; NHS England | 17 June 2019 | — | | ministerial_meetings |
| recorded as meeting | Cisco | 12 June 2019 | — | | ministerial_meetings |
| recorded as meeting | British Generic Manufacturers Association | 11 June 2019 | — | | ministerial_meetings |
| recorded as meeting | Gilead | 11 June 2019 | — | | ministerial_meetings |
| recorded as meeting | GENOMICS plc | 10 June 2019 | — | | ministerial_meetings |
| recorded as meeting | The Institute of Cancer Research; London Borough of Sutton | 6 June 2019 | — | | ministerial_meetings |
| recorded as meeting | Anthony Nolan; Alkaptonuria Society; Amicus Therapeutics; Asthma UK; BioMarin; Brittle Bone Society; CSL Behring; Cystic Fibrosis Trust; Fanconi Hope Charitable Trust; Fight for Sight; Gilead; Liver4life; Society for Mucopolysaccharide Diseases; MS Society; MSA Trust; Muscular Dystrophy UK; National AIDS Trust; Neurological Alliance; Niemann-Pick UK; Novartis; Patient representative for thalassaemia; Pulmonary Hypertension Association UK; Scleroderma & Raynaud's UK; Sickle Cell Society; Sobi; Spinal Injuries Association; The Aplastic Anaemia Trust; The Children's Trust; The Haemophilia Society; The Patients Association; UK Primary Immune-deficiency Patient Support | 5 June 2019 | — | | ministerial_meetings |
| recorded as meeting | Sir Henry Bellingham MP and his constituent, Dr. Andrew Llewelyn | 5 June 2019 | — | | ministerial_meetings |
| recorded as meeting | Meeting with Bee'ah | 14 May 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health and Social Care; Office for Life Sciences; Department for International Trade; Department of Business, Energy and Industrial Strategy; Association of British HealthTech Industries; International Business Machines UKI; Medtronic; Smith and Nephew; ConvaTec; Abbott; Owen Mumford; Accelerated Access Collaborative; NHS Confederation; Johnson and Johnson | 13 May 2019 | — | | ministerial_meetings |
| recorded as meeting | Association of British HealthTech Industries | 9 May 2019 | — | | ministerial_meetings |
| recorded as meeting | Novo Nordisk Ltd | 9 May 2019 | — | | ministerial_meetings |
| recorded as meeting | Amazon Web Services | 9 May 2019 | — | | ministerial_meetings |
| recorded as meeting | Asthma UK | 8 May 2019 | — | | ministerial_meetings |
| recorded as meeting | The British-Danish Pharma Alliance | 7 May 2019 | — | | ministerial_meetings |
| recorded as meeting | Phone call with Professor Sir John Bell | 30 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Health Data Research UK | 30 April 2019 | — | | ministerial_meetings |
| recorded as meeting | CMR Surgical | 29 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Cambridge University Hospitals NHS Foundation Trust and Cambridge Global Health Partnerships | 29 April 2019 | — | | ministerial_meetings |
| recorded as meeting | AstraZeneca | 29 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Wellcome Sanger | 29 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health & Social Care; Department for Exiting the European Union; Office for Life Sciences; NHS England; Medicines and Healthcare Products Regulatory Agency; Her Majesty's Treasury; Department for International Trade; GlaxoSmithKline; Association of the British Pharmaceutical Industry; AstraZeneca; BioIndustry Association; Association of the British Pharmaceutical Industry; Philips; Cancer Research UK | 25 April 2019 | — | | ministerial_meetings |
| recorded as meeting | The Ehlers-Danlos Society | 9 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Tessa Jowell Brain Cancer Mission and Cancer Research UK Cambridge Institute | 4 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Healthwatch England | 4 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Roche Products UK | 4 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Roche Diagnostics | 4 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Biogen; Amgen; Amicus; Celgene; Gilead; Lilly; Pfizer; Hanover | 3 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Pfizer | 3 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Association of Medical Research Charities | 3 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Cancer Research UK | 2 April 2019 | — | | ministerial_meetings |
| recorded as meeting | The King�s Fund | 2 April 2019 | — | | ministerial_meetings |
| recorded as meeting | Intro meeting with L Marks Limited | 1 April 2019 | — | | ministerial_meetings |
| recorded as meeting | IQVIA | 28 March 2019 | — | | ministerial_meetings |
| recorded as meeting | Association of Medical Research Charities; Academy of Medical Sciences; Wellcome Trust; Ada Lovelace Institute; Future Care Capital; NHS England | 28 March 2019 | — | | ministerial_meetings |
| recorded as meeting | EU Relationship Group (EURG) Government
Nicola Blackwood, Department of Health & Social Care � co-chair
Matt Hancock, Department of Health & Social Care
Eoin Parker, Department for Exiting the European Union
Tamsin Berry, Office for Life Sciences
Steve Oldfield, Department of Health & Social Care
Keith Willett, National Health Service
Dr Ian Hudson, Medicines and Healthcare Products Regulatory Agency
Patrick Carey, Medicines and Healthcare Products Regulatory Agency
Sir Michael Rawlins, Medicines and Healthcare Products Regulatory Agency
Liz Woodeson, Department of Health & Social Care
Matthew Porter, Home Office
David Lunn, Her Majesty's Treasury
David Sheppard, Department for International Trade
Clara Swinson, Department of Health & Social Care Observers
David Boyd, AstraZeneca
Elliot Dunster, Association of the British Pharmaceutical Industry
Laura Collister, BioIndustry Association
Eleanor Newman, GlaxoSmithKline
Natalie de Lima, GlaxoSmithKline
Ellie Charsley, ABHI
Helen Farmer, Office for Life Sciences
Ellis Stacey, Office for Life Sciences
Andrew Howard, Office for Life Sciences
Richard Phillips, ABHI
Georgie Holmes, Department for Exiting the European Union
Heather Hobson, Her Majesty's Treasury Industry
Phil Thomson, GlaxoSmithKline � co-chair
Juliette White, AstraZeneca
Mike Thompson, Association of the British Pharmaceutical Industry
Steve Bates, BioIndustry Association
Elizabeth Littlewood, Philips
Emma Greenwood, Cancer Research UK
Peter Ellingworth, ABHI
Malcolm Weir, Heptares | 14 March 2019 | — | | ministerial_meetings |
| recorded as meeting | BioIndustry Association | 14 March 2019 | — | | ministerial_meetings |
| recorded as meeting | The Association of the British Pharmaceutical Industry | 14 March 2019 | — | | ministerial_meetings |
| recorded as meeting | Independent Fetal Anti Convulsant Trust and Norman Lamb MP | 13 March 2019 | — | | ministerial_meetings |
| recorded as meeting | Merck Sharp & Dohme | 5 March 2019 | — | | ministerial_meetings |
| recorded as meeting | AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Association for British Pharmaceutical Industry, Association for British HealthTech Industry, BioIndustry Association, Philips United Kingdom and Ireland, United Kingdom Research and Innovation Medical Research Council, National Health Service Digital, National Health Service England, Wellcome Trust, Legal & General, Accelerated Access Collaborative, Department for International Trade, Merck Sharp & Dohme, Union Chimique Belge | 4 March 2019 | — | | ministerial_meetings |
| recorded as meeting | Smith & Nephew | 27 February 2019 | — | | ministerial_meetings |
| recorded as meeting | Proprietary Association of Great Britain | 19 February 2019 | — | | ministerial_meetings |
| recorded as meeting | Biogen | 14 February 2019 | — | | ministerial_meetings |
| recorded as meeting | Scripps Research | 11 February 2019 | — | | ministerial_meetings |
| recorded as meeting | Professor Sir John Bell (Regius Chair of Medicine at the University of Oxford) | 7 February 2019 | — | | ministerial_meetings |
| recorded as meeting | National Genomics Board | 7 February 2019 | — | | ministerial_meetings |
| recorded as meeting | EU Relationship Group Government
Nicola Blackwood, Department of Health & Social Care � co-chair
Lord Henley, Department for Business, Energy & Industrial Strategy
Robin Walker, Department for Exiting the European Union
Stephen Hammond, Department of Health & Social Care
Steve Oldfield, Department of Health & Social Care
Keith Willett, National Health Service
Dr Ian Hudson, Medicines and Healthcare Products Regulatory Agency
Jonathan Mogford, Medicines and Healthcare Products Regulatory Agency
Patrick Carey, Medicines and Healthcare Products Regulatory Agency
Sir Michael Rawlins, Medicines and Healthcare Products Regulatory Agency
David Simmons, Office for Life Sciences
Liz Woodeson, Department of Health & Social Care
Deborah Kobewka, Department for International Trade
David Lunn, Her Majesty's Treasury Observers
David Boyd, AstraZeneca
Elliot Dunster, Association of the British Pharmaceutical Industry
Laura Collister, BioIndustry Association
Eleanor Newman, GlaxoSmithKline
Ellie Charsley, ABHI
Helen Farmer, Office for Life Sciences
Ellis Stacey, Office for Life Sciences
Andrew Howard, Office for Life Sciences
Emily Weston, Department for Exiting the European Union
Heather Hobson, Her Majesty's Treasury
Alec Jackson, Department of Health & Social Care Industry
Phil Thomson, GlaxoSmithKline � co-chair
Juliette White, AstraZeneca
Mike Thompson, Association of the British Pharmaceutical Industry
Steve Bates, BioIndustry Association
Elizabeth Littlewood, Philips
Emlyn Samuel, Cancer Research UK
Richard Phillips, ABHI
Malcolm Weir, Heptares | 30 January 2019 | — | | ministerial_meetings |
| recorded as meeting | GlaxoSmithKline | 28 January 2019 | — | | ministerial_meetings |
| recorded as meeting | Association of British Healthtech Industries | 21 January 2019 | — | | ministerial_meetings |
| recorded as meeting | HSBC Holdings | 21 January 2019 | — | | ministerial_meetings |
| recorded as meeting | Meeting with Jon Symonds and Jan Hall | 21 January 2019 | — | | ministerial_meetings |
| recorded as meeting | Department of Health and Social Care; Office for Life Sciences; Department for Business, Energy and Industrial Strategy; Prof Sir John Bell; AstraZeneca; GlaxoSmithKline; Johnson and Johnson; MSD; UCB; Association of the British Pharmaceutical Industry; Association of British HealthTech Industries; BioIndustry Association; Philips; Medical Research Council; Health Data Research UK; NHS Digital; Innovate UK; Genomics England; AstraZeneca; UK Biobank; Wellcome Trust; NHS England; Accelerated Access Collaborative; Cambridge Universith Hospitals NHS Foundation Trust | — | — | | ministerial_meetings |